TrialPain2020

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety.

John D Markman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.